Mannkind Corp
NASDAQ: MNKD
$6.84
-$0.06 (-0.9%)
Closing Price on November 22, 2024
MNKD Articles
Last week, a few biotech companies made absolutely massive runs, while others had serious falls.
Published:
Last Updated:
RBC Capital Markets downgraded MannKind on Wednesday to Underperform from a Market Perform, with a price target of a mere dollar.
Published:
Last Updated:
Wednesday's top analyst upgrades, downgrades and initiations include Avis Budget, Baker Hughes, Enphase Energy, Hecla Mining, MannKind, Nokia, Tesla and US Steel.
Published:
Last Updated:
The October 15 short interest data have been compared with the previous figures, and short interest mixed in these selected biotech stocks.
Published:
Between the September 30 and November 15 settlement dates, Apple displaced BlackBerry as it continued to climb the list of the most heavily shorted stocks traded on the Nasdaq.
Published:
Last Updated:
The September 30 short interest data have been compared with the previous figures, and short interest increased in most of these selected biotech stocks for this settlement date.
Published:
Between the September 15 and September 30 settlement dates, short interest in many of the most heavily shorted stocks traded on the Nasdaq dwindled somewhat.
Published:
The September 15 short interest data have been compared with the previous figures, and short interest in these selected stocks increased across the board for this settlement date.
Published:
A surge in Apple shares sold short between the August 31 and September 15 settlement dates was the most notable move in among the most heavily shorted stocks traded on the Nasdaq.
Published:
The short interest data are out for the August 31 settlement date. Short interest in the selected biotech stocks increased across the board for this settlement date.
Published:
Between the August 14 and August 31, Sirius XM was dethroned as the most heavily shorted stock traded on the Nasdaq.
Published:
Wednesday’s top analyst upgrades, downgrades and initiations include Celgene, Ciena, Goldman Sachs, MannKind, Newfield Exploration, Tetraphase Pharmaceuticals, Walgreens Boots Alliance and Yingli...
Published:
The short interest data are out for the August 14 settlement date. Biotech companies are considered a riskier group of stocks.
Published:
A modest increase in short interest between the July 31 and August 14 settlement dates was enough for Sirius XM to reclaim the top spot on the list of the most heavily shorted stocks traded on the...
Published:
The short interest data are out for the July 31 settlement date, and overall, short interest in the selected biotech stocks backed off for this period.
Published: